• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

RPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNN details
Primary information
ID antitb_1256,
Name23716047
N-Terminal modificationEosinophil Cationic Protein (RNase 3)
C-Terminal ModificationRPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNN
Chemical ModificationFree
Linear/CyclicFree
LengthDisulphide linkage
ChiralityCyclic
Nature70
SourceL
OriginCationic
SpeciesNatural
StrainSecreted by eosinophil secondary granules
Inhibition ConcentrationMycobacterium vaccae
In Vitro/ In vivoMycobacterium vaccae strain (ATCC 15483)
Cell LineMIC = 20.0 ± 1.0 μM
Inhibition ConcentrationIn vitro
Sequence2013
CytotoxicityNone
In vivo ModelNA
Lethal DoseNA
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyMembrane depolarization and permeabilization
Other activitiesCell envelope
PMIDNone
Year of PublicationAntibacterial and Antiparasitic
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1257,
Name23716047
N-Terminal modificationEosinophil Cationic Protein (RNase 3)
C-Terminal ModificationRPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNN
Chemical ModificationFree
Linear/CyclicFree
LengthDisulphide linkage
ChiralityCyclic
Nature70
SourceL
OriginCationic
SpeciesNatural
StrainSecreted by eosinophil secondary granules
Inhibition ConcentrationMycobacterium vaccae
In Vitro/ In vivoMycobacterium vaccae strain (ATCC 15483)
Cell LineIC50 = 11.6 ± 0.2 μM
Inhibition ConcentrationIn vitro
Sequence2013
CytotoxicityNone
In vivo ModelNA
Lethal DoseNA
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyMembrane depolarization and permeabilization
Other activitiesCell envelope
PMIDNone
Year of PublicationAntibacterial and Antiparasitic
Tertiary Structure
(Technique)
Not Predicted),